Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CD4+ T Cell Dependent B Cell Recovery and Function After Autologous Hematopoietic Stem Cell Transplantation.

Frontiers in immunology - 1 Jan 2021

Heck Clarissa, Steiner Sophie, Kaebisch Eva M, Frentsch Marco, Wittenbecher Friedrich, Scheibenbogen Carmen, Hanitsch Leif G, Nogai Axel, le Coutre Philipp, Bullinger Lars, Blau Igor-Wolfgang, Na Il-Kang

Abstract excerpt

Introduction: High-dose chemotherapy followed by autologous hematopoietic stem cell transplantation (auto-HSCT) represents a standard treatment regime for multiple myeloma (MM) patients. Common and potentially fatal side effects after auto-HSCT are infections due to a severely compromised immune system with hampered humoral and cellular immunity. This study delineates in depth the quantitative and functional B...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents, Alkylating
Share to Chemotherapy, Adjuvant

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Immunocompromised Host

Share to Melphalan

Share to Multiple Myeloma

Share to Neoadjuvant Therapy

Share to Recovery of Function

Share to Transplantation, Autologous

Source

Open in PubMed Open full text

Identifiers

PMID: 34659226
DOI: 10.3389/fimmu.2021.736137
PMCID: PMC8519398

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CD4+ T Cell Dependent B Cell Recovery and Function After Autologous Hematopoietic Stem Cell Transplantation.PMID 34659226Read ↗

Molecular mechanisms promoting long-term cytopenia after BCMA CAR-T therapy in Multiple MyelomaSemantic proximity Read ↗

Hematopoiesis and immune reconstitution after CD19 directed chimeric antigen receptor T‐cells (CAR‐T): A comprehensive review on incidence, risk factors and current managementSemantic proximity Read ↗

International Myeloma Working Group consensus approach to the treatment of multiple myeloma patients who are candidates for autologous stem cell transplantationSemantic proximity Read ↗

Effect of daratumumab on stem cell yields in patients with newly diagnosed multiple myeloma: a report from the Multiple Myeloma GroupSemantic proximity Read ↗

Functional immune reconstitution after allogeneic hematopoietic stem cell transplantation in myeloablative and non-myeloablative conditioned patientsSemantic proximity Read ↗

Applications of Multiparameter Flow Cytometry in the Diagnosis, Prognosis and Monitoring of Multiple Myeloma PatientsSemantic proximity Read ↗

T-helper phenotypes in the blood of myeloma patients on ECOG phase III trials E9486/E3A93.Semantic proximity Read ↗

Strategies for Salvage Therapy Post CAR-T Therapy Failure in Refractory/Relapsed Multiple Myeloma PatientsSemantic proximity Read ↗

The bone marrow of myeloma patients is steadily inhabited by a normal-sized pool of functional regulatory T cells irrespectiveof the disease status.Semantic proximity Read ↗

Impact of clonal hematopoiesis on clinical outcomes to BCMA CAR-T in multiple myelomaSemantic proximity Read ↗

Clonal hematopoiesis and differential outcomes after immune checkpoint blockadeSemantic proximity Read ↗

The future of autologous stem cell transplantation in myelomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.